Table 5.
Cost-Effectiveness Analysis of Stem Cell Transplantation (SCT) for Acute Leukemia in Children*
| Stem Cell Grafts | Total Cost (C) | Incremental Cost (ΔC) | Effectiveness (%treatment success) (E) | Incremental Effectiveness (ΔE) | ICER (ΔC/ΔE) |
|---|---|---|---|---|---|
| Standard Risk Group | |||||
| BMT | $352,885 | 80.3% | |||
| PBSCT | $512,294 | $159,409 | 57.1% | <0 | −$687,108 |
| High Risk Group | |||||
| BMT | $457,078 | 23.5% | |||
| PBSCT | $377,316 | −$79,762 | 18.8% | −4.7% | $1,697,063 |
Actual and Imputed total costs were included